Regulatory guidance and validation science for digital endpoints are solid. The real barrier is cross-functional execution – and the cost of waiting is compounding.
- Sites Are Building Their Own Tech – SCRS On What That Means
- Human-In-The-Loop In AI Validation And Control: From Principle To Practice
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
- Real-World Evidence And Wearables Are Reshaping Trial Tech
- Navigating Elsa's AI Transition: Practical Guidance To Safeguard Confidential Information (Part 3)
- HEOR, AI, And The Future Of Clinical Trial Technology
- AI Amplifies Capabilities But Also Risks: Learn The Legal Consequences Of AI In Clinical Research
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
We Need Regulatory Clarity—Not Complexity In Clinical Trial Technology
The current U.S. deregulatory momentum should not diminish compliance standards but instead serve as a call to streamline and modernize regulatory guidance.
-
Flexible Integrations To Reduce Risks And Increase Efficiencies
Learn how a trial team kept the blind of central lab samples and patient treatment across a Phase III and extension trial, whilst optimizing the supply chain.
-
5 Benefits Of Using A Study Management Tool
See how study management tools simplify clinical trial management by centralizing all study information, enhancing efficiency and precision, and more.
-
Virtual eConsent For Decentralized Trials
Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.
-
Top HEOR Trends
Real-world evidence (RWE) offers insights into the effectiveness of medical treatments in everyday settings, with various stakeholders utilize RWE to enhance healthcare.
-
Effectively Working With A Research Technology Vendor During Implementation
In order to get the most out of your vendor partnership, here are steps to take when working with your vendor as you adopt and implement their technology for your organization.
-
Why The Everest Group Named Medable A Leader In eCOA
Discover how this eCOA is leading the charge in accelerating study timelines, boosting patient engagement, and answering real sponsor needs.
-
Increase Participant Diversity With eClinical Tools
The right technology and community partnerships can help sponsors meet FDA diversity requirements without additional expenditures, build relationships with minorities, and prepare for future trials.
-
Why "Good Enough" Data Is Good Enough For Agentic AI
Overcome 'data paralysis' and learn why you don’t need perfect data to start leveraging AI and its benefits, and why starting today is much better than waiting for 'perfect.'
-
Clinical Data Like You've Never Seen It Before
In a recent webinar, experts from Revvity Signals Software explored how solutions like its Spotfire platform enable better, more streamlined clinical studies.
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- Sites Are Building Their Own Tech – SCRS On What That Means
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
RECENT NEWSLETTERS
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More